Dr. Dharmender Kumar appointed Director & Chief – Public Affairs as Senior Management Personnel
Board of Max Healthcare Institute Ltd approved the appointment of Dr. Dharmender Kumar as Director & Chief – Public Affairs, identified as Senior Management Personnel, with effect from November 1, 2026.
By ScoutQuest · · 2 min read
- Appointee / Role
- Dr. Dharmender Kumar as Director & Chief – Public Affairs, Senior Management Personnel
- Effective Date
- November 1, 2026
- Capex Approved
- ~₹93 Crore for Max Super Speciality Hospital, Sector-128, Noida; ~₹97 Crore for Max Super Speciality Hospital, Vaishali
The management change
- The Board approved the appointment of Dr. Dharmender Kumar as Director & Chief - Public Affairs, identified as Senior Management Personnel, with effect from November 1, 2026.
- The appointment was made based on the recommendation of the Nomination and Remuneration Committee.
The board meeting was held on October 30, 2026, and is described as commencing at 12.50 pm (IST) and concluding at 2.35 pm (IST).
Capital expenditure approved
- ~₹93 Crore towards the redevelopment and clinical capacity enhancement programme at Max Super Speciality Hospital, Sector-128, Noida. The hospital is run and operated by Crosslay Remedies Limited (formerly Jaypee Healthcare Limited), a wholly-owned subsidiary of the Company.
- ~₹97 Crore towards construction of additional floors over the existing tower at Max Super Speciality Hospital, Vaishali, also run and operated by Crosslay Remedies Limited.
Gurugram hospital project updated
- The Board approved a revision of the project cost for the proposed ~525 bedded hospital at Sector - 56, Gurugram to ~₹1,143 Crore, and the timeline for completion to April 2027.
- The revision is attributed primarily to changes in façade specifications, additional construction requirements, development of the atrium and enhanced interior fit-outs. Other aspects of the project, apart from the revised project cost and completion timeline, remain unchanged.
Financial results approved
- The Board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, based on the Audit Committee's recommendation, together with unmodified limited review reports from the statutory auditors, S.R. Batliboi & Co. LLP.
- On a consolidated basis, revenue from operations for the quarter ended September 30, 2026 was ₹2,56,921 lakhs, profit for the period was ₹41,445 lakhs, and basic earnings per share was ₹4.26.
What this means for a retail reader
A senior management appointment is a routine board-level disclosure. The accompanying capex approvals and the revised Gurugram project cost and timeline are the larger financial items in the same update, and they tell you how the company is allocating money to expand hospital capacity over the coming years.
Also from Max Healthcare Institute
Q2 FY27: revenue up 20% YoY to ₹ 3,219 Cr, PAT up 10% YoY to ₹ 448 Cr
30 Oct 2026
Max Healthcare Institute Ltd press release, Q2 FY27
30 Oct 2026
Consolidated results for the September 30, 2026
30 Oct 2026
More numbers
- Capex approved for Max Super Speciality Hospital, Sector-128, Noida₹93 Crore
- Capex approved for Max Super Speciality Hospital, Vaishali₹97 Crore
- Revised project cost, hospital at Sector-56, Gurugram₹1,143 Crore
- Capacity of proposed Gurugram hospital (beds)525 bedded
- Consolidated revenue from operations, quarter ended September 30, 20262,56,921
- Consolidated profit for the quarter ended September 30, 202641,445
- Consolidated basic EPS for the quarter ended September 30, 20264.26
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.